TY - JOUR
T1 - The role of α-klotho in human cancer
T2 - molecular and clinical aspects
AU - Ligumsky, Hagai
AU - Merenbakh-Lamin, Keren
AU - Keren-Khadmy, Noa
AU - Wolf, Ido
AU - Rubinek, Tami
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2022/9/30
Y1 - 2022/9/30
N2 - Klotho is a well-established longevity hormone. Its most prominent function is the regulation of phosphate homeostasis. However, klotho possesses multiple pleiotropic activities, including inhibition of major signaling pathways, reducing oxidative stress and suppressing inflammation. These activities are tightly associated with cancer, and klotho was discovered as a universal tumor suppressor. We review here novel molecular aspects of klotho activity in cancer, focusing on its structure–function relationships and clinical aspects regarding its expression, blood levels, clinical risk, and prognostic value in the clinical setting. In addition, the potential benefit of klotho treatment combined with chemotherapy, biological therapy, or immunotherapy, are discussed. Finally, as klotho was shown in preclinical models to inhibit cancer development and growth, we discuss various approaches to developing klotho-based therapies.
AB - Klotho is a well-established longevity hormone. Its most prominent function is the regulation of phosphate homeostasis. However, klotho possesses multiple pleiotropic activities, including inhibition of major signaling pathways, reducing oxidative stress and suppressing inflammation. These activities are tightly associated with cancer, and klotho was discovered as a universal tumor suppressor. We review here novel molecular aspects of klotho activity in cancer, focusing on its structure–function relationships and clinical aspects regarding its expression, blood levels, clinical risk, and prognostic value in the clinical setting. In addition, the potential benefit of klotho treatment combined with chemotherapy, biological therapy, or immunotherapy, are discussed. Finally, as klotho was shown in preclinical models to inhibit cancer development and growth, we discuss various approaches to developing klotho-based therapies.
UR - http://www.scopus.com/inward/record.url?scp=85137014898&partnerID=8YFLogxK
U2 - 10.1038/s41388-022-02440-5
DO - 10.1038/s41388-022-02440-5
M3 - Review article
C2 - 36038662
AN - SCOPUS:85137014898
SN - 0950-9232
VL - 41
SP - 4487
EP - 4497
JO - Oncogene
JF - Oncogene
IS - 40
ER -